We describe the first experiments to relate the cerebral kinetics of isoflurane (determined by fluorine magnetic resonance spectroscopy) to cerebral function. Using a surface receive coil we found two-compartment kinetics within the head with equilibrium half-times of 3.5 min and approximately 1 h with respect to expired isoflurane concentrations. Using critical fusion flicker frequency as an objective measure of the cerebral effect of isoflurane, we found evidence to identify the fast component as the brain. Responsiveness to command was lost at a brain partial pressure of 0.3% isoflurane. We conclude that the measured cerebral kinetics of isoflurane exactly matched the predictions of the classical perfusion-limited model. (Br.
The tissue kinetics of isoflurane can be followed in vivo by fluorine magnetic resonance spectroscopy ( 19 F MRS). The first part of this study 1 reported the first such measurements in humans and demonstrated biexponential elimination from the head, which supports the predictions of the standard, perfusion-limited pharmacokinetic model. The concentration of isoflurane was too small to confirm spatial localization by 19 F magnetic resonance imaging, so in this part we report our experience with functional localization, that is relating tissue compartment concentrations of isoflurane deduced from MRS data to their cerebral effect. Such studies can only be performed in human subjects.
Subjects and methods
Most of the details of the subjects and methods have been reported in part I of this study 1 ; only an overview and additional details are given here. In essence, volunteers were placed in a magnetic resonance spectrometer and breathed 0.6-1% isoflurane in oxygen. The end-expired isoflurane concentration was measured by an infrared analyser. A coil placed over their occiput collected MRS data. With this arrangement the amount of signal depends on the amount of isoflurane in the coil's receptive field, but the shape and regional sensitivity of this field is not known exactly.
Subjects were attended by two anaesthetists: one remained outside the spectrometer's radio frequency screening enclosure watching the electronic monitors, the other was inside the enclosure monitoring respiration and assessing the level of sedation by prompting the subject to press a communication bleeper at 1-min intervals. After the fourth experiment a system for monitoring critical flicker fusion (CFF) was included in the study. A red LED placed against a black background on the side wall of the bore of the magnet was observed by the subject who held a micro switch. Wires from these were passed through radio frequency filters to a computer which controlled the rate of flicker from outside the spectrometer. The flicker decreased by 1 Hz every second from 45 Hz until the subject pressed the micro switch to indicate that the flickering was visible. This fusion flicker frequency was stored on hard disk, the LED turned off for 3 s, then the process repeated. CFF is conventionally the average of fusion flicker (decreasing rate of flicker) and flicker fusion (increasing rate of flicker) frequencies. We were unable to measure the flicker fusion frequency contemporaneously because heavily sedated subjects confused flicker fusion runs with fusion flicker runs. The simple instruction to "Click when it flickers" was the most such subjects could manage in the relative isolation of the magnet bore.
An intra-arterial cannula was sited in four studies of three subjects. After a short period during which baseline measurements were made, a constant concentration of isoflurane (0.6-1%) was introduced into the inspired gas. Arterial blood analysis was used to confirm that the end-expired isoflurane concentration was being measured accurately in gas aspirated along a 6-m catheter, using a technique similar to that described by Landon and colleagues 2 and modified later in our laboratory. 3 A computer model of up to three parallel compartments was also developed in which the isoflurane partial pressure in each compartment was increased or decreased in proportion to the difference between the measured end-expired and modelled compartment partial pressures. Specifically:
where PEЈ(t) and P i (t):partial pressures in expired gas and the ith compartment, respectively at time t; k i :compartment rate constant; ␦ i :time interval between t and t;1. ␦ i was 10 s-the interval between consecutive data sets from the gas analyser. The model total MRS signal is given by:
where W i :weighting factor of the ith compartment and n:number of compartments used in the model. The weighting factor may be considered as the product of a pharmacokinetic factor (which depends on the capacity of the compartment for isoflurane) and a spatial scaling factor (which depends on the regional sensitivity of the coil to the MR signal). These two components are constant in time. The least squares fit of the model to the actual MR data was made by manipulating one pair of variables for each compartment: the rate constant (k i ) and a weighting factor (W i ) for the contribution of that compartment to the total MRS signal. All modelling was performed by iteration using the Solver function of a Microsoft Excel v4 spreadsheet, with least squares solutions approximated from several initial variable values and checked visually to ensure that true minima had been found. The F test criterion of Boxenbaum, Riegelman and Elashoff 4 was used to determine the number of compartments appropriate for each subject's data.
The model enabled us to use all data acquired during complete studies, and the early data collected during studies which were terminated prematurely because of restlessness before wash-out data were collected. Furthermore, because the wash-in and wash-out data were modelled to the expired gas concentration, the effect of changes in ventilation on the elimination of isoflurane did not affect the rate constants for the compartments identified by the model.
During dynamic studies such as these, hysteresis between drug concentrations in different locations and their biological effect provide evidence of the site of drug action: lack of hysteresis is circumstantial evidence of site of effect. When CFF frequency results were available during both wash-in and wash-out they were plotted as functions of isoflurane concentrations in either expired gas or the tissue compartments and inspected for evidence of hysteresis.
We also sought evidence of hysteresis between losing and gaining responsiveness to command. The actual brain isoflurane concentrations at these moments should have small variance. We therefore normalized each group of data (expired gas, fast and slow compartments) by dividing by its mean and compared variances by the F test.
Results
A total of eight studies were undertaken on five volunteers (see table 1 ). Expired isoflurane concentrations were not stored during our pilot study, and therefore these data cannot be used here. Only four studies produced both wash-in and wash-out MRS data and an example is shown in figure 1 . In most instances the other studies were terminated prematurely because the subject became restless before regaining consciousness. When this happened the subject was withdrawn immediately from the magnet bore and wash-out data were lost. In one study the first measured 19 F signal was greater than those immediately after. Although no cause could be found at the time, this was assumed to be a technical problem and the study was abandoned. For safety, the subject was removed from the magnet bore and allowed to recover under direct observation so that wash-out data could not be acquired. Analysis of those MRS data (excluding the first measurement) The best fit when the two-compartment model for each data set was constrained to share group half-times showed single compartment kinetics and it seems likely that signal was received initially from the fast compartment but then the subject moved, displacing the surface coil so that it collected data from superficial tissues only. Arterial partial pressures were measured in four studies of three subjects. During wash-in, values were 80-95% of end-expired partial pressures. There was a similar, but reversed, gradient during wash-out. Four of the seven sets of data modelled against expired isoflurane concentration supported a twocompartment model (P:0.005), giving a mean of 3.5 min for the fast half-time (table 1). As both wash-in and wash-out measurements took place over a 40-min period each, processes with half-times greater than this period were poorly determined. No data set supported a three-compartment model. When the data were pooled, two-compartment models were strongly supported over onecompartment models (P:0.00001) with group rate constants equivalent to half-times of 4.8 and 135 min.
Only two studies produced CFF data during both wash-in and wash-out. These are shown together in figure 2 . Hysteresis is clearly present in the plot of CFF against expired isoflurane, but this is absent when CFF is plotted against isoflurane in the fast compartment.
Four subjects lost and regained responsiveness to command while in the spectrometer ( fig. 3) , two of these on more than one occasion as irregular respiration caused the expired isoflurane concentration to increase and decrease. When normalized by division by the group mean, the variance in the fast compartment was less than in the expired gas (P:0.0005) or the slow compartment (P:0.00001).
Discussion
The difficulties of clinical monitoring of patients in a spectrometer are now well understood and relatively easy to overcome. 5 Assessment of the conscious level of a subject in the magnet bore who cannot speak because of the mouthpiece, and is in any case required to keep as still as possible, remains troublesome and limits pharmacodynamic conclusions. As a crude indicator of consciousness, subjects operated a whistle by squeezing a hand-held bulb in response to a command from the attending anaesthetist. This requires consistent verbal delivery of the command which must gain the subject's attention without startling him (which could precipitate movement). CFF is a more refined measure of cognitive impairment and was introduced later in the series of experiments. We decided that alternatives such as response time would risk movement artefact in sedated subjects.
Respired gas was sampled close to the mouth from a breathing system which depended on careful placement and facial tone to maintain a seal at the mouth. The sample was obtained along a 6-m line, which increases both transit and response times of the Datex Ultima. The accuracy of our measurements of isoflurane in end-expired gas is therefore open to question, so we obtained frequent arterial blood samples during four studies. In general we found that during wash-in arterial partial pressures followed measured expired gas partial pressures with a brief lag and small gradient, similar to the findings of other investigators. 6 7 We have found evidence of two tissue compartments filling from the isoflurane tension in alveolar gas. The surface coil we used collected MRS data from a region of the head, including skin, fat, bone and brain, by acting as an aerial over the occiput. Three factors affect the fluorine MRS signal received from each tissue: the concentration of isoflurane within the tissue, its proximity to the receive coil and the chemical environment of the fluorine atoms in that tissue. Pharmacokinetic theory can predict the concentration of isoflurane in each tissue, but the contribution to the total MRS signal cannot be determined a priori. The weights calculated for each compartment therefore hold no clue as to their physical representation which remains undetermined because the MRS signal in our experiments was too weak to allow imaging. Our data strongly support the brain as the source of the fast compartment signal because (i) the kinetics of our model matched well those predicted by classical pharmacokinetic theory; (ii) the hysteresis observed when CFF was related to expired gas was lost when it is related to the fast compartment (although these data came from only two subjects); (iii) the moments of losing and regaining responsiveness were related to a relatively constant fast component isoflurane concentration. Although marked variation in anaesthetic distribution within the brain has been demonstrated on a small scale, 8 there is no evidence to suggest the existence of two compartments large enough to be detected by the spectrometer yet having such different kinetics. Anaesthetics are generally approximately half as soluble in grey as in white matter 9 so even with its greater perfusion, 10 the grey matter should equilibrate no more than six times faster. The fact that we obtained a fluorine signal from a single compartment when the coil was displaced also suggests that the slow compartment is superficial and spatially separated from the brain.
Although we have few complete studies they are in close agreement and are supported by our other results. The fast compartment correlates with objective measures of anaesthetic effect. We have sufficient confidence in these data to believe that further repetition-with the potential risks to the subjects-is not justified until technical improvements allow localization of the signal. Our findings support the classical perfusion-limited pharmacokinetic theory of inhalation anaesthesia.
